Showing 5,601 - 5,620 results of 42,307 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 50 ((mg decrease) OR (a decrease)) ))', query time: 0.69s Refine Results
  1. 5601

    Earth-Abundant Fe and Ni Dually Doped Co<sub>2</sub>P for Superior Oxygen Evolution Reactivity and as a Bifunctional Electrocatalyst toward Renewable Energy-Powered Overall Alkalin... by Jiangtian Li (1284543)

    Published 2021
    “…In this paper, we report multimetallic phosphide FeNi-Co<sub>2</sub>P as a superior alkaline oxygen evolution reaction (OER) electrocatalyst and bifunctional electrocatalyst for solar energy-powered water splitting. …”
  2. 5602

    Earth-Abundant Fe and Ni Dually Doped Co<sub>2</sub>P for Superior Oxygen Evolution Reactivity and as a Bifunctional Electrocatalyst toward Renewable Energy-Powered Overall Alkalin... by Jiangtian Li (1284543)

    Published 2021
    “…In this paper, we report multimetallic phosphide FeNi-Co<sub>2</sub>P as a superior alkaline oxygen evolution reaction (OER) electrocatalyst and bifunctional electrocatalyst for solar energy-powered water splitting. …”
  3. 5603

    Cyanoamino acid metabolism. by Qiang Li (8118)

    Published 2025
    “…In KEGG of 8d, the objective genes were drastically enriched cyanoamino acid metabolism, glycine, serine and threonine metabolism, phenylalanine metabolism, etc. We further constructed the pathway for cyanide amino acid metabolism under B stress and found that miR408c-5p targeted the gene controlling β -glucosidase 18, and the expression level was notably decreased. …”
  4. 5604

    Antioxidation and Anti-Inflammatory Activity of Prussian Blue Nanozymes to Alleviate Acetaminophen-Induced Acute Liver Injury by Qiang Feng (88137)

    Published 2023
    “…The mechanism of liver injury induced by APAP is mainly related to oxidative stress and inflammatory reaction. Herein, we report a simple and efficient one-step synthesis of Prussian blue (PB) nanozymes with multiple antioxidant enzymatic activities that effectively treat APAP-induced DILI. …”
  5. 5605

    Fluorescence Imaging of Neuroblastocyte Differentiation and Parkinson’s Brain Tissue Lesions Examined by a Norepinephrine-Activated Molecular Probe by Huming Yan (9917374)

    Published 2025
    “…Compared to the previously developed probe <i><b>SXU-NEQ</b></i>, the self-fluorescence intensity of probe <i><b>DQF</b></i> decreased significantly (I<i><sub><b>DQF</b></sub></i>/I<i><sub><b>SXU‑NEQ</b></sub></i> = 35%). …”
  6. 5606

    Expression analysis of miRNAs by qRT-PCR. by Qiang Li (8118)

    Published 2025
    “…In KEGG of 8d, the objective genes were drastically enriched cyanoamino acid metabolism, glycine, serine and threonine metabolism, phenylalanine metabolism, etc. We further constructed the pathway for cyanide amino acid metabolism under B stress and found that miR408c-5p targeted the gene controlling β -glucosidase 18, and the expression level was notably decreased. …”
  7. 5607

    DataSheet1_The influence of drug-induced metabolic enzyme activity inhibition and CYP3A4 gene polymorphism on aumolertinib metabolism.docx by Feng Ye (173489)

    Published 2024
    “…The IC<sub>50</sub> values of telmisartan and carvedilol in CYP3A4.1 were 6.68 ± 1.76 μM and 0.60 ± 0.25 μM, respectively, whereas in CYP3A4.12, the IC<sub>50</sub> exceeded 100 μM. …”
  8. 5608

    Study Flowchart. by Jae-Heung Cho (798319)

    Published 2025
    “…For determining cost-effectiveness, quality-adjusted life years (QALY) were analyzed, and the incremental cost-effectiveness ratios from the societal and healthcare system perspectives were calculated. At week 5, the visual analog scale (VAS) scores decreased more in the CMT group than in the control group, although the difference was statistically insignificant. …”
  9. 5609

    Changes in outcomes over time. by Jae-Heung Cho (798319)

    Published 2025
    “…For determining cost-effectiveness, quality-adjusted life years (QALY) were analyzed, and the incremental cost-effectiveness ratios from the societal and healthcare system perspectives were calculated. At week 5, the visual analog scale (VAS) scores decreased more in the CMT group than in the control group, although the difference was statistically insignificant. …”
  10. 5610

    Enhanced Li-Ion Conductivity and Air Stability of Sb-Substituted Li<sub>4</sub>GeS<sub>4</sub> toward All-Solid-State Li-Ion Batteries by Jihun Roh (15411343)

    Published 2023
    “…However, H<sub>2</sub>S gas release in ambient air is a critical issue for realizing scalable production of these materials. In the present study, we designed aliovalent substitutions of Sb<sup>5+</sup> for Ge<sup>4+</sup> in Li<sub>4</sub>GeS<sub>4</sub> to produce a series of materials with a general nominal composition of Li<sub>4–<i>x</i></sub>Ge<sub>1–<i>x</i></sub>Sb<sub><i>x</i></sub>S<sub>4</sub>. …”
  11. 5611

    Study timetable. by Jae-Heung Cho (798319)

    Published 2025
    “…For determining cost-effectiveness, quality-adjusted life years (QALY) were analyzed, and the incremental cost-effectiveness ratios from the societal and healthcare system perspectives were calculated. At week 5, the visual analog scale (VAS) scores decreased more in the CMT group than in the control group, although the difference was statistically insignificant. …”
  12. 5612

    Cumulative incidence curves of recovery by group. by Jae-Heung Cho (798319)

    Published 2025
    “…For determining cost-effectiveness, quality-adjusted life years (QALY) were analyzed, and the incremental cost-effectiveness ratios from the societal and healthcare system perspectives were calculated. At week 5, the visual analog scale (VAS) scores decreased more in the CMT group than in the control group, although the difference was statistically insignificant. …”
  13. 5613
  14. 5614

    Table_7_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

    Published 2021
    “…</p><p>Results: Upon exclusion of participants identified as previously exposed to SARS-CoV-2, seroconversion at t1 was lower in patients than controls (29 and 50%, respectively, p = 0.0014), while the second vaccine dose served as a boost in both cohorts (91 and 95% positivity, respectively, at t2, p = 0.2463). …”
  15. 5615

    Table_1_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

    Published 2021
    “…</p><p>Results: Upon exclusion of participants identified as previously exposed to SARS-CoV-2, seroconversion at t1 was lower in patients than controls (29 and 50%, respectively, p = 0.0014), while the second vaccine dose served as a boost in both cohorts (91 and 95% positivity, respectively, at t2, p = 0.2463). …”
  16. 5616

    Table_2_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

    Published 2021
    “…</p><p>Results: Upon exclusion of participants identified as previously exposed to SARS-CoV-2, seroconversion at t1 was lower in patients than controls (29 and 50%, respectively, p = 0.0014), while the second vaccine dose served as a boost in both cohorts (91 and 95% positivity, respectively, at t2, p = 0.2463). …”
  17. 5617

    Table_10_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

    Published 2021
    “…</p><p>Results: Upon exclusion of participants identified as previously exposed to SARS-CoV-2, seroconversion at t1 was lower in patients than controls (29 and 50%, respectively, p = 0.0014), while the second vaccine dose served as a boost in both cohorts (91 and 95% positivity, respectively, at t2, p = 0.2463). …”
  18. 5618

    Image_1_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

    Published 2021
    “…</p><p>Results: Upon exclusion of participants identified as previously exposed to SARS-CoV-2, seroconversion at t1 was lower in patients than controls (29 and 50%, respectively, p = 0.0014), while the second vaccine dose served as a boost in both cohorts (91 and 95% positivity, respectively, at t2, p = 0.2463). …”
  19. 5619

    Table_8_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

    Published 2021
    “…</p><p>Results: Upon exclusion of participants identified as previously exposed to SARS-CoV-2, seroconversion at t1 was lower in patients than controls (29 and 50%, respectively, p = 0.0014), while the second vaccine dose served as a boost in both cohorts (91 and 95% positivity, respectively, at t2, p = 0.2463). …”
  20. 5620

    Presentation_1_Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up.pdf by André Weigert (7888712)

    Published 2021
    “…</p><p>Results: Upon exclusion of participants identified as previously exposed to SARS-CoV-2, seroconversion at t1 was lower in patients than controls (29 and 50%, respectively, p = 0.0014), while the second vaccine dose served as a boost in both cohorts (91 and 95% positivity, respectively, at t2, p = 0.2463). …”